Clinical Research Solutions

Generex Signs Binding Licensing & Research Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Malaysia | BioSpace | 9/18/2020

… have agreed to collaborate and have developed a strategy towards the rapid development of the Ii-Key-CoV-2 vaccine for Malaysia. As part of that strategy, Generex has identified a local CRO, Jigsaw Clinical Research Solutions (https://www.jigsawclinical.com/), managed by U.S. industry veteran, Jeffrey Yablon who has decades of experience in clinical development and regulatory affairs, and has established Jigsaw as the premier Malaysian CRO. Generex CEO, Joseph Moscato …

Veridata EDC: Data security benefits of Elsevier’s electronic data capture solution | 9/17/2020

… applications and protected data, working to the best security practices. Team members working on Veridata EDC undertake regular training in order to remain educated on international data security regulations and how they relate to clinical research solutions like Veridata EDC. Elsevier’s in-house Security & Compliance team monitor and validate our processes as well as technical and functional specifications to ensure we continue to meet the demands of ISO 27001 and …

Follow Clinical Research Solutions:    

CATO SMS Acquires Array Biostatistics | PR Newswire | 9/15/2020

… Sep 15, 2020, 06:00 ET Share this article CARY, N.C. , Sept. 15, 2020 /PRNewswire/ – CATO SMS announced today that it has acquired Wilmington, NC -based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions . The company plans to invest in growing Array and its highly regarded biostatistical capabilities. Both Array and CATO SMS offer highly specialized services that expedite and support drug development for small and emerging …

CATO SMS ACQUIRES ARRAY BIOSTATISTICS | 9/15/2020

… Expands Specialized Clinical Research Offering with Enhanced Biostatistical Services CARY, N.C., September 15, 2020 – CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions . The company plans to invest in growing Array and its highly regarded biostatistical capabilities. Both Array and CATO SMS offer highly specialized services that expedite and support drug development for small and emerging …

CATO SMS Acquires Array Biostatistics | BioSpace | 9/15/2020

CATO SMS Acquires Array Biostatistics Published: Sep 15, 2020 CARY, N.C. , Sept. 15, 2020 /PRNewswire/ – CATO SMS announced today that it has acquired Wilmington, NC -based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions . The company plans to invest in growing Array and its highly regarded biostatistical capabilities. Both Array and CATO SMS offer highly specialized services that expedite and support drug development for small and …

CATO SMS Acquires Array Biostatistics - PharmaVOICE : PharmaVOICE | 9/15/2020

… Expands Specialized Clinical Research Offering with Enhanced Biostatistical Services CARY, N.C., September 15, 2020 – CATO SMS announced today that it has acquired Wilmington, NC-based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions . The company plans to invest in growing Array and its highly regarded biostatistical capabilities. Both Array and CATO SMS offer highly specialized services that expedite and support drug development for small and emerging …

CATO SMS Acquires Array Biostatistics | 9/15/2020

… cato-sms.com By CATO SMS;Array Biostatistics; Save CARY, N.C. , Sept. 15, 2020 /PRNewswire/ – CATO SMS announced today that it has acquired Wilmington, NC -based Array Biostatistics (Array) to expand its offering of specialized clinical research solutions . The company plans to invest in growing Array and its highly regarded biostatistical capabilities. Both Array and CATO SMS offer highly specialized services that expedite and support drug development for small and emerging …

Promotions of Gerard Barron and Juliet Hulse | 9/9/2020

Promotions of Gerard Barron and Juliet Hulse Promotions of Gerard Barron and Juliet Hulse Illingworth Announces Promotions of Gerard Barron and Juliet Hulse Illingworth Research Group , a globally respected, patient-focused clinical research solutions provider, is pleased to announce the promotions of two of its senior management team, Gerard Barron and Juliet Hulse. Gerard Barron will assume the role of Vice President, Global Operations, and Juliet Hulse will assume the …

Inteliquet Appoints Jean Roberson as Chief Financial Officer | Malvern Daily Record | 8/12/2020

… Jean Roberson as Chief Financial Officer. Jean has an impressive career nurturing companies and empowering them to raise equity, grow sales, and accelerate operations. (Photo: Business Wire) “As demand for Inteliquet’s digital, data-driven clinical research solutions increases, we’re excited to have Jean’s multi-faceted expertise in raising venture and private capital funding, and developing strong business models,” said Lamont. “Jean is a true strategic financial partner and she adds …

Inteliquet Appoints Jean Roberson as Chief Financial Officer | BioSpace | 8/12/2020

… Jean Roberson as Chief Financial Officer. Jean has an impressive career nurturing companies and empowering them to raise equity, grow sales, and accelerate operations. (Photo: Business Wire) “As demand for Inteliquet’s digital, data-driven clinical research solutions increases, we’re excited to have Jean’s multi-faceted expertise in raising venture and private capital funding,and developing strong business models,” said Lamont. “Jean is a true strategic financial partner and she adds …

Inteliquet Appoints Jean Roberson as Chief Financial Officer | Business Wire | 8/12/2020

… Jean Roberson as Chief Financial Officer. Jean has an impressive career nurturing companies and empowering them to raise equity, grow sales, and accelerate operations. (Photo: Business Wire) “As demand for Inteliquet’s digital, data-driven clinical research solutions increases, we’re excited to have Jean’s multi-faceted expertise in raising venture and private capital funding, and developing strong business models,” said Lamont. “Jean is a true strategic financial partner and she adds …

Inteliquet Appoints Jean Roberson as Chief Financial Officer | Business Wire | 8/12/2020

… hired Jean Roberson, CPA, as Chief Financial Officer (CFO). In her new role, she will report directly to Inteliquet’s President and Chief Operating Officer, Marie E. Lamont. “As demand for Inteliquet’s digital, data-driven clinical research solutions increases, we’re excited to have Jean’s multi-faceted expertise in raising venture and private capital funding, and developing strong business models,” said Lamont. “Jean is a true strategic financial partner and she adds …

JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications | PR Newswire | 8/6/2020

… their current brand names, ARCA Recycling and GeoTraq, both of which are undergoing review to determine appropriate strategic alternatives. For more information, visit janone.com About CATO SMS CATO SMS is a provider of specialized clinical research solutions . The company was formed when CATO Research LLC and Specialized Medical Services-oncology B.V. (SMS-oncology) merged in 2019. With more than 30 years of experience focusing on the needs of small and …

Nutter Represents Ce3, Inc. in Acquisition by Catalyst Clinical Research | 8/6/2020

Nutter served as legal counsel to Ce3, Inc., a full-service CRO focused on providing early phase oncology clinical development services to the biotechnology industry, in connection with its acquisition by Catalyst Clinical Research, a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry. The legal team was led by Shannon Zollo and included Josh French , Meghan Kelly , and AJ Santaniello on corporate matters; Michael …

Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO | PR Newswire | 8/5/2020

… thoroughly understanding the needs of biotechnology companies while providing high-quality, cost-effective solutions to support their clients’ analytical, regulatory, and investor goals. About Catalyst Catalyst is a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry. With offices in the US and EU, the company provides global resourcing solutions, functional and full-service managed solutions, the latter with a focus on oncology therapeutics. Catalyst’s …

Peter B. Malamis | 6/17/2020

… and biotechnology companies, contract research organizations (CROs), and other biopharma related groups using patient data. He also oversees the expansion of the company’s life sciences offerings. “As demand for Inteliquet’s unique digital, data-driven clinical research solutions steadily increases, we’re excited to have Peter lead our efforts in this area,” said Marie E. Lamont, Inteliquet’s Interim President and Chief Operating Officer. “The current pandemic intensified the attention on one of …

Inteliquet Taps Industry Veteran Peter B. Malamis to Lead Life Sciences Group | Business Wire | 6/4/2020

… implement trials faster, as well as with more precision in their design and recruitment. Inteliquet’s offering enables better trial designs and faster patient identification and enrollment. “As demand for Inteliquet’s unique digital, data-driven clinical research solutions steadily increases, we’re excited to have Peter lead our efforts in this area,” said Marie E. Lamont, Inteliquet’s Interim President and Chief Operating Officer. “The current pandemic intensified the attention on one of …

Peter B. Malamis to Lead Life Sciences Group. | 6/4/2020

… implement trials faster, as well as with more precision in their design and recruitment. Inteliquet’s offering enables better trial designs and faster patient identification and enrollment. “As demand for Inteliquet’s unique digital, data-driven clinical research solutions steadily increases, we’re excited to have Peter lead our efforts in this area,” said Marie E. Lamont, Inteliquet’s Interim President and Chief Operating Officer. “The current pandemic intensified the attention on one of …

ArcheMedX Bolsters Team, Appoints Kelly Ritch as Vice President Clinical Research Solutions | 11/14/2019

… readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform , with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 years of clinical operations experience to accelerate growth of the company’s clinical research business. “As the complexity and cost of clinical research increases, a key to reducing the …

ArcheMedX Bolsters Team, Appoints Kelly Ritch as Vice President Clinical Research Solutions | PRWeb | 11/14/2019

ArcheMedX , the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform , with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 years of clinical operations experience to accelerate growth of the company’s clinical research business. “As the complexity and cost of clinical research …

Veeva Brings Artificial Intelligence to Drug Safety | Business & Finance | heraldchronicle.com | Business Wire | 8/13/2019

… and submissions. “There is a significant opportunity to reduce the number of manual processes in drug safety,” said Dr. Lisa Hornick, chief medical officer at Catalyst Clinical Research, a global CRO providing flexible, customized, clinical research solutions to the biopharmaceutical industry. “Using artificial intelligence to automate case intake will speed case processing and allow our pharmacovigilance organization to spend less time on data entry.” Life sciences companies are collecting an …

Veeva Brings Artificial Intelligence to Drug Safety | Markets Insider | Business Insider | 8/13/2019

… and submissions. “There is a significant opportunity to reduce the number of manual processes in drug safety,” said Dr. Lisa Hornick, chief medical officer at Catalyst Clinical Research, a global CRO providing flexible, customized, clinical research solutions to the biopharmaceutical industry. “Using artificial intelligence to automate case intake will speed case processing and allow our pharmacovigilance organization to spend less time on data entry.” Life sciences companies are collecting an …

Forte Presents Winners of the Fall 2017 MAGI Award for Excellence in Site Payments | PRWeb | 11/14/2017

Forte, an industry-leading developer of clinical research solutions , helped announce the winners of the 2017 Fall MAGI Award for Excellence in Site Payments at MAGI’s Clinical Research Conference on November 12, 2017 in San Francisco, CA. Forte partnered with MAGI to further analyze industry trends in site payments and to celebrate and recognize sponsors and CROs that pay sites promptly and consistently. Over 40,000 payment records were contributed by …

Miltenyi Biotec Offers Clinical Research Solutions with Chimeric Antigen Receptors | PRWeb | 10/26/2017

Chimeric Antigen Receptor (CAR)-transduced T lymphocytes have demonstrated impressive clinical activity against B cell malignancies in phase I trials. In most instances, lentivirus-based or a retrovirus-based gene vectors were used to introduce the therapeutic gene expression cassette into the genome of T lymphocytes. The gene expression cassette is composed of an internal promoter and the CAR, created by splicing together of extracellular antigen-binding motifs, linker and …

Clinical Operations

ArcheMedX Bolsters Team, Appoints Kelly Ritch as Vice President Clinical Research Solutions | 11/14/2019

Kelly Ritch’s addition better equips ArcheMedX to scale the capabilities it provides to transform clinical operations. CHARLOTTESVILLE, Va. (PRWEB) November 14, 2019 ArcheMedX , the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform , with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 …

ArcheMedX Bolsters Team, Appoints Kelly Ritch as Vice President Clinical Research Solutions | PRWeb | 11/14/2019

ArcheMedX , the company improving clinical trial readiness, today announced the expansion of its senior leadership team. To support increasing demand for Ready, the company’s clinical trials platform , with sponsors and CROs, ArcheMedX has appointed Kelly Ritch as Vice President of Clinical Research Solutions. Kelly will apply her 20 years of clinical operations experience to accelerate growth of the company’s clinical research business. “As the complexity and cost of clinical research …